Jarlenski M - Search Results

1

Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.

Jarlenski M, Hogan C, Bogen DL, Chang JC, Bodnar LM, Van Nostrand E. Jarlenski M, et al. Womens Health Issues. 2017 May-Jun;27(3):264-270. doi: 10.1016/j.whi.2016.12.008. Epub 2017 Jan 24. Womens Health Issues. 2017. PMID: 28129942 Free PMC article.

2

Association between support from a health professional and breastfeeding knowledge and practices among obese women: evidence from the Infant Practices Study II.

Jarlenski M, McManus J, Diener-West M, Schwarz EB, Yeung E, Bennett WL. Jarlenski M, et al. Womens Health Issues. 2014 Nov-Dec;24(6):641-8. doi: 10.1016/j.whi.2014.08.002. Epub 2014 Sep 18. Womens Health Issues. 2014. PMID: 25239780

3

Pregnant Women's Access to Information About Perinatal Marijuana Use: A Qualitative Study.

Jarlenski M, Tarr JA, Holland CL, Farrell D, Chang JC. Jarlenski M, et al. Womens Health Issues. 2016 Jul-Aug;26(4):452-9. doi: 10.1016/j.whi.2016.03.010. Epub 2016 May 4. Womens Health Issues. 2016. PMID: 27131908 Free PMC article.

4

Public health messages about perinatal marijuana use in an evolving policy context.

Jarlenski M, Zank J, Tarr J, Chang JC. Jarlenski M, et al. Subst Abus. 2017 Jan-Mar;38(1):48-54. doi: 10.1080/08897077.2016.1268240. Epub 2016 Dec 7. Subst Abus. 2017. PMID: 27925865 Free PMC article.

5

Filled Prescriptions for Opioids After Vaginal Delivery.

Jarlenski M, Bodnar LM, Kim JY, Donohue J, Krans EE, Bogen DL. Jarlenski M, et al. Obstet Gynecol. 2017 Mar;129(3):431-437. doi: 10.1097/AOG.0000000000001868. Obstet Gynecol. 2017. PMID: 28178050 Free PMC article.

6

State Medicaid Coverage of Medically Necessary Abortions and Severe Maternal Morbidity and Maternal Mortality.

Jarlenski M, Hutcheon JA, Bodnar LM, Simhan HN. Jarlenski M, et al. Obstet Gynecol. 2017 May;129(5):786-794. doi: 10.1097/AOG.0000000000001982. Obstet Gynecol. 2017. PMID: 28383380 Free PMC article.

7

Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged women.

Jarlenski M, Koma JW, Zank J, Bodnar LM, Bogen DL, Chang JC. Jarlenski M, et al. Am J Obstet Gynecol. 2017 Dec;217(6):705-707. doi: 10.1016/j.ajog.2017.08.015. Epub 2017 Aug 24. Am J Obstet Gynecol. 2017. PMID: 28843740 Free PMC article. No abstract available.

8

Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.

Saunders JB, Jarlenski MP, Levy R, Kozhimannil KB. Saunders JB, et al. Womens Health Issues. 2018 Mar-Apr;28(2):130-136. doi: 10.1016/j.whi.2017.10.011. Epub 2017 Nov 26. Womens Health Issues. 2018. PMID: 29183818 Review.

9

Media portrayal of prenatal and postpartum marijuana use in an era of scientific uncertainty.

Jarlenski M, Koma JW, Zank J, Bodnar LM, Tarr JA, Chang JC. Jarlenski M, et al. Drug Alcohol Depend. 2018 Jun 1;187:116-122. doi: 10.1016/j.drugalcdep.2018.02.021. Epub 2018 Apr 11. Drug Alcohol Depend. 2018. PMID: 29655873 Free PMC article.

10

Obstetric and Pediatric Provider Perspectives on Mandatory Reporting of Prenatal Substance Use.

Jarlenski M, Minney S, Hogan C, Chang JC. Jarlenski M, et al. J Addict Med. 2019 Jul/Aug;13(4):258-263. doi: 10.1097/ADM.0000000000000489. J Addict Med. 2019. PMID: 30550393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters